ART with long-term effects without immunosuppression

Published Date: 02 Mar 2023

The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Obesity linked to subsequent neoplasms in childhood cancer survivors

2.

Investigations may result in novel combination therapies for early-stage lung cancers.

3.

A new theranostic drug targets different cancer types.

4.

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

5.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot